 |
인쇄하기
취소
|
MSD Korea to launch Vytorin for an anti-cholestrolemia.
MSD Korea announced to launch Vytorin, a new type of anti-cholesterol drug containing 2 medicines, ezetimibe and simvastatin, blocking cholesterol absorption in duplicate in the process of cholesterol synthesis in the liver, starting from July 1 this year.
MSD Korea said that Vitorin is administered as an alternative to diet therapy for the patients who are diagnosed with a primary and mixed...
MSD Korea said that Vitorin is administered as an alternative to diet therapy for the patients who are diagnosed with a primary and mixed...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.